Preparation of tumor-specific boron compounds. 1. In vitro studies using boron-labeled antibodies and elemental boron as neutron targets.
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D001880:Boranes / Q000138:chemical synthesis; D001895:Boron / Q000528:radiation effects / Q000627:therapeutic use*; D002417:Cattle; D003979:Diazonium Compounds / Q000138:chemical synthesis; D006648:Histocompatibility; D006801:Humans; D007106:Immune Sera; D008214:Lymphocytes / Q000276:immunology / Q000528:radiation effects; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009502:Neutrons; D011817:Rabbits; D011830:Radiation Effects; D012710:Serum Albumin, Bovine; D013045:Species Specificity
D000906:Antibodies; D001880:Boranes; D003979:Diazonium Compounds; D007106:Immune Sera; D012710:Serum Albumin, Bovine; D001895:Boron